Sign in
4

Changes in Ownership

X4 Pharmaceuticals, Inc Filed Acc 0001628280-24-004263

Chief Financial Officer sold 27,721 shares at $1.01 ($27,973)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mostafa Adam S. Chief Financial Officer 2024-02-12 Sale −27,721 $1.01 $27,973 52,500 D
Open-market sales · 27,721 sh · avg $1.01 · $27,973
Loading xslF345X05/wk-form4_1707775417.xml…